Most brokerages have cut earnings per share (EPS) estimates on Nestle India on the backdrop of moderation in growth momentum in the near term ...

While Sun Pharma continues to demonstrate strength in its branded and specialty businesses, concerns around US generics, R&D investments, and regulatory hurdles leave brokerages divided on its outlook ...

ITC ended the last weekly session of January on a positive note, with the upside of over 1.1%. Next week, the stock will be in focus for its upcoming interim dividend and Q3 results.

Join us on the M&M Stock Liveblog, your hub for real-time updates and comprehensive analysis on a prominent stock. Stay in ...

Sun Pharma reported a 15% YoY rise in Q3FY25 profit to Rs 2,903 crore, surpassing estimates. Revenue grew 10% to Rs 13,675.5 crore, driven by domestic and emerging markets. API sales rose 22%, while ...